# Postprandial Glucose Level Decreases and Appetite in Adults Without Diabetes

**Authors:** Jiali Yao, Sarah M. Edney, Linda Wei Lin Tan, Shih Ling Kao, Xueling Sim, E Shyong Tai, Falk Müller-Riemenschneider, Rob M. van Dam

PMC · DOI: 10.1001/jamanetworkopen.2026.3426 · JAMA Network Open · 2026-03-26

## TL;DR

This study found that drops in blood sugar after meals are linked to increased hunger and quicker eating in non-diabetic adults.

## Contribution

The study identifies postprandial glucose level decreases as a potential biomarker for appetite regulation in free-living adults.

## Key findings

- Larger postprandial glucose decreases were associated with greater hunger 2-4 hours after meals.
- Participants with glucose levels below baseline ate sooner than those without such drops.
- The findings suggest postprandial glucose decreases could be a target for weight management strategies.

## Abstract

Are postprandial glucose level decreases associated with appetite among free-living adults without diabetes?

In this cohort study of 7650 meals from 895 participants, postprandial glucose level decreases in the 2- to 3-hour period after meals varied widely. Postprandial glucose level decreases were associated with greater postprandial hunger at 2 to 3 hours and 3 to 4 hours and with a shorter time to the initiation of the next food intake.

Our findings support postprandial glucose level decrease as a potential biomarker to enhance understanding of appetite regulation and as a potential target for appetite and weight management.

This cohort study examines the association between postprandial glucose level decreases and appetite regulation among adults without diabetes in Singapore.

Biomarkers that can predict appetite and be monitored in daily life could guide appetite and weight management. Glucose level declines induce hunger in laboratory settings, but free-living data are limited.

To characterize postprandial glucose level decreases (PGDs) 2 to 3 hours following free-choice meals and estimate the association of PGDs with appetite.

This cohort study, conducted from May 2021 to August 2024, used intensive longitudinal data from smartphone app–based ecologic momentary assessments (EMA) and continuous glucose monitoring (CGM) over 9 days among Singaporean adults without diabetes. Data were analyzed between November 2024 and August 2025.

Two CGM-derived PGD measures per meal: PGD magnitude (percentage of glucose level reduction 2 to 3 hours after meals compared with the premeal baseline level) and PGD below the baseline level (binary indicator coded as yes when PGD magnitude was >0).

The main outcomes were 6 EMA-derived appetite measures, including hunger level and hunger increase 2 to 3 hours and 3 to 4 hours after meals, time to the next meal, and time to the next meal or snack. Multivariable generalized estimating equation models estimated the adjusted association for each pair of PGD exposure (PGD magnitude, PGD below the baseline level) and the appetite measure.

The analysis included 7650 meals from 895 participants (mean [SD] age, 40.1 [13.6] years; 561 [63%] female). Median time to the next meal was 380 (IQR, 285-660) minutes when PGD was below the baseline level (4121 meals [54%]) compared with 425 (IQR, 325-714) minutes when PGD below the baseline level was absent. Larger PGD magnitudes were associated with greater postprandial hunger levels at 2 to 3 hours (β = 0.05 [95% CI, 0.03-0.07] per 10% decrease) and 3 to 4 hours (β = 0.09 [95% CI, 0.06-0.13] per 10% decrease), greater hunger increases at 2 to 3 hours (β = 0.08 [95% CI, 0.04-0.12] per 10% decrease) and 3 to 4 hours (β = 0.07 [95% CI, 0.02-0.12] per 10% decrease), and shorter time to the next meal (β = −6.30 [95% CI, −8.88 to −3.72] minutes) and the next meal or snack (β = −6.54 [95% CI, −8.88 to −3.72] minutes). Similarly, PGD below the baseline level was associated with all appetite measures, including a shorter time to the next meal (β = −27.30 [95% CI, −36.90 to −17.71] minutes).

In this cohort study of adults without diabetes, PGD was associated with greater perceived hunger and earlier subsequent eating. Our findings support PGD as a potential biomarker for appetite regulation and target for weight management.

## Full-text entities

- **Genes:** PHGDH (phosphoglycerate dehydrogenase) [NCBI Gene 26227] {aka 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, GIP (gastric inhibitory polypeptide) [NCBI Gene 2695]
- **Diseases:** type 2 diabetes (MESH:D003924), Obesity (MESH:D009765), prediabetes (MESH:D011236), Diabetes (MESH:D003920), reduced hunger (MESH:D001523), arthritis (MESH:D001168), cardiovascular diseases (MESH:D002318), cancer (MESH:D009369), Hypoglycemia (MESH:D007003), hyperglycemia (MESH:D006943), appetite (MESH:D001068)
- **Chemicals:** alcohol (MESH:D000438), blood glucose (MESH:D001786), Glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13022734/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13022734/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC13022734/full.md

---
Source: https://tomesphere.com/paper/PMC13022734